A method for treating a condition selected from the group consisting of type 2 diabetes mellitus, obesity, NAFLD, nonalcoholic steatohepatitis, dyslipidemia, and metabolic syndrome, comprising administering to a patient in need thereof, an effective amount of a compound, or a pharmaceutically acceptable salt thereof, as claimed by 72
Drzedon, J., Jacewicz, D., & Chmurzyski, L
You can explore professional guidance through Healthcare.pro to determine whether this treatment aligns with your needs
Nutritional carnitine is actively (sodium-dependent) and passively transported from the intestinal content into enterocytes, with 5486% bioavailability, depending on the amount of carnitine in the meal
Previous studies demonstrated that MTX administration provoked JAK1 and STAT3 phosphorylation in rat models of intestinal injury and hepatotoxicity using MTX (Hassanein et al